The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-[4-[(4-amino-1-bicyclo[2.2.2]octanyl)methoxy]-3-fluoro-phenyl]-1-methyl-pyrazolo[3,4-d]pyrimidin-6-amine ID: ALA4748638
PubChem CID: 129073171
Max Phase: Preclinical
Molecular Formula: C21H25FN6O
Molecular Weight: 396.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1nc(-c2ccc(OCC34CCC(N)(CC3)CC4)c(F)c2)c2cnc(N)nc21
Standard InChI: InChI=1S/C21H25FN6O/c1-28-18-14(11-25-19(23)26-18)17(27-28)13-2-3-16(15(22)10-13)29-12-20-4-7-21(24,8-5-20)9-6-20/h2-3,10-11H,4-9,12,24H2,1H3,(H2,23,25,26)
Standard InChI Key: JGBLHVKRSBVZJG-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
13.3791 -14.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3779 -15.1616 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0901 -15.5747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0883 -13.9208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6630 -13.9213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8052 -14.3302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8100 -15.1571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5983 -15.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0797 -14.7363 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5905 -14.0686 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8426 -13.2817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8594 -16.1895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3049 -16.8036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5655 -17.5869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3748 -17.7528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9230 -17.1333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6637 -16.3523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7322 -17.2957 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.6370 -18.5364 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4458 -18.7047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7038 -19.4842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1561 -20.0985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4153 -20.8793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2195 -21.0477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7723 -20.4330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5127 -19.6458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4787 -21.8323 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6976 -20.2482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3620 -20.2482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
1 5 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 6 1 0
10 11 1 0
8 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
16 18 1 0
15 19 1 0
19 20 1 0
21 20 1 0
21 22 1 0
21 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
24 27 1 0
21 28 1 0
28 29 1 0
29 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 396.47Molecular Weight (Monoisotopic): 396.2074AlogP: 3.18#Rotatable Bonds: 4Polar Surface Area: 104.87Molecular Species: BASEHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.73CX LogP: 2.63CX LogD: -0.23Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.70Np Likeness Score: -1.00
References 1. Alper PB,Deane J,Betschart C,Buffet D,Collignon Zipfel G,Gordon P,Hampton J,Hawtin S,Ibanez M,Jiang T,Junt T,Knoepfel T,Liu B,Maginnis J,McKeever U,Michellys PY,Mutnick D,Nayak B,Niwa S,Richmond W,Rush JS,Syka P,Zhang Y,Zhu X. (2020) Discovery of potent, orally bioavailable in vivo efficacious antagonists of the TLR7/8 pathway., 30 (17): [PMID:32738975 ] [10.1016/j.bmcl.2020.127366 ]